However, insulin treatment is often introduced in advanced stages of T2DM with an increase in the incidence of both microvascular and macrovascular complications, i.e., visual impairment or neuropathy, which may also contribute to falls and increase the risk of fractures [86], suggesting a broader combined effect of insulin treatment on bone metabolism. Here, INS is linked to neuropathy.